| Sterling Biotech has reported a standalone total income from operations of Rs 118.08 crore and a net loss of Rs 88.48 crore for the quarter ended Jun '15. Other income for the quarter was Rs 1.19 crore. | | For the quarter ended Jun 2014 the standalone total income from operations was Rs 185.66 crore and net loss was Rs 110.27 crore, and other income Rs 1.30 crore. | | Sterling Bio shares closed at 5.80 on August 17, 2015 (NSE) and has given -17.14% returns over the last 6 months and -54.51% over the last 12 months. |
|
| | Sterling Biotech | | Standalone Quarterly Results | -------- in Rs. Cr. -------- |
|
| Jun '15 | Mar '15 | | | Jun '14 | | Net Sales/Income from operations | 116.90 | 100.63 | | | 184.36 | | Other Operating Income | 1.19 | 1.43 | | | 1.30 | | Total Income From Operations | 118.08 | 102.06 | | | 185.66 | | EXPENDITURE | | | | | | | Consumption of Raw Materials | 79.71 | 173.30 | | | 224.80 | | Purchase of Traded Goods | -- | -- | | | -- | | Increase/Decrease in Stocks | -3.47 | -105.49 | | | -98.61 | | Power & Fuel | -- | -- | | | -- | | Employees Cost | 13.45 | 12.27 | | | 12.61 | | Depreciation | 70.17 | 70.50 | | | 64.06 | | Excise Duty | -- | -- | | | -- | | Admin. And Selling Expenses | -- | -- | | | -- | | R & D Expenses | -- | -- | | | -- | | Provisions And Contingencies | -- | -- | | | -- | | Exp. Capitalised | -- | -- | | | -- | | Other Expenses | 7.03 | 8.82 | | | 8.90 | | P/L Before Other Inc. , Int., Excpt. Items & Tax | -48.81 | -57.34 | | | -26.09 | | Other Income | -- | -- | | | -- | | P/L Before Int., Excpt. Items & Tax | -48.81 | -57.34 | | | -26.09 | | Interest | 82.17 | 76.39 | | | 127.52 | | P/L Before Exceptional Items & Tax | -130.98 | -133.74 | | | -153.61 | | Exceptional Items | -- | -- | | | -- | | P/L Before Tax | -130.98 | -133.74 | | | -153.61 | | Tax | -42.50 | -43.39 | | | -49.84 | | P/L After Tax from Ordinary Activities | -88.48 | -90.35 | | | -103.77 | | Prior Year Adjustments | -- | -- | | | -6.50 | | Extra Ordinary Items | -- | -- | | | -- | | Net Profit/(Loss) For the Period | -88.48 | -90.35 | | | -110.27 | | Equity Share Capital | 27.20 | 27.20 | | | 26.80 | | Reserves Excluding Revaluation Reserves | -- | -- | | | -- | | Equity Dividend Rate (%) | -- | -- | | | -- | | EPS Before Extra Ordinary | | | | | | | Basic EPS | -3.25 | -3.32 | | | -3.87 | | Diluted EPS | -2.04 | -2.09 | | | -2.40 | | EPS After Extra Ordinary | | | | | | | Basic EPS | -3.25 | -3.32 | | | -4.11 | | Diluted EPS | -2.04 | -2.09 | | | -2.55 | | Public Share Holding | | | | | | | No Of Shares (Crores) | 13.55 | 13.55 | | | 13.19 | | Share Holding (%) | 49.82 | 49.82 | | | 49.20 | | Promoters and Promoter Group Shareholding | | | | | | | a) Pledged/Encumbered | | | | | | | - Number of shares (Crores) | 5.08 | 5.08 | | | 5.08 | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | 55.94 | 55.94 | | | 55.94 | | - Per. of shares (as a % of the total Share Cap. of the company) | 18.68 | 18.68 | | | 18.97 | | b) Non-encumbered | | | | | | | - Number of shares (Crores) | 4.00 | 4.00 | | | 4.00 | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | 44.06 | 44.06 | | | 44.06 | | - Per. of shares (as a % of the total Share Cap. of the company) | 14.71 | 14.71 | | | 14.94 | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
